These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7790079)

  • 1. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion.
    Dong ZM; Murphy JW
    Infect Immun; 1995 Jul; 63(7):2632-44. PubMed ID: 7790079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.
    Dong ZM; Murphy JW
    Infect Immun; 1993 Dec; 61(12):5067-77. PubMed ID: 8225584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.
    Dong ZM; Murphy JW
    Infect Immun; 1995 Mar; 63(3):770-8. PubMed ID: 7868246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans.
    Doyle HA; Murphy JW
    J Leukoc Biol; 1997 Feb; 61(2):147-55. PubMed ID: 9021919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunity in a cutaneous model of cryptococcosis.
    Domer JE; Lyon FL; Murphy JW
    Infect Immun; 1983 Jun; 40(3):1052-9. PubMed ID: 6343238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.
    Capilla J; Maffei CM; Clemons KV; Sobel RA; Stevens DA
    Med Mycol; 2006 Nov; 44(7):601-10. PubMed ID: 17071553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcal polysaccharides bind to CD18 on human neutrophils.
    Dong ZM; Murphy JW
    Infect Immun; 1997 Feb; 65(2):557-63. PubMed ID: 9009313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of cytoplasmic yeast antigens of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii by immune human sera.
    Hamilton AJ; Figueroa JI; Jeavons L; Seaton RA
    FEMS Immunol Med Microbiol; 1997 Feb; 17(2):111-9. PubMed ID: 9061357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice.
    Mandel MA; Grace GG; Orsborn KI; Schafer F; Murphy JW; Orbach MJ; Galgiani JN
    Infect Immun; 2000 Nov; 68(11):6196-201. PubMed ID: 11035725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.
    Muth SM; Murphy JW
    Infect Immun; 1995 May; 63(5):1645-51. PubMed ID: 7729868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of experimental nephrosis by culture filtrate of Cryptococcus neoformans var. gattii (CneF).
    Mirshafiey A; Razavi A; Mehrabian F; Moghaddam MR; Hadjavi M
    Immunopharmacol Immunotoxicol; 2002 Aug; 24(3):349-64. PubMed ID: 12375733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.
    Buchanan KL; Murphy JW
    Infect Immun; 1993 Jul; 61(7):2854-65. PubMed ID: 8514388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of Cryptococcus neoformans from immunologically suppressed mice.
    Murphy JW
    Infect Immun; 1989 Jul; 57(7):1946-52. PubMed ID: 2499541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s).
    Khakpour FR; Murphy JW
    Infect Immun; 1987 Jul; 55(7):1657-62. PubMed ID: 2954914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil.
    Rozenbaum R; Gonçalves AJ; Wanke B; Caiuby MJ; Clemente H; Lazera Mdos S; Monteiro PC; Londero AT
    Mycopathologia; 1992 Sep; 119(3):133-6. PubMed ID: 1435954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
    Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
    J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens.
    Murphy JW; Mosley RL; Cherniak R; Reyes GH; Kozel TR; Reiss E
    Infect Immun; 1988 Feb; 56(2):424-31. PubMed ID: 3123390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.
    Lim TS; Murphy JW
    Infect Immun; 1980 Oct; 30(1):5-11. PubMed ID: 7002791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity among strains of Cryptococcus neoformans var. gattii as revealed by a sequence analysis of multiple genes and a chemotype analysis of capsular polysaccharide.
    Sugita T; Ikeda R; Shinoda T
    Microbiol Immunol; 2001; 45(11):757-68. PubMed ID: 11791669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.
    Hansakon A; Ngamskulrungroj P; Angkasekwinai P
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.